Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A09327 | 31789772 | J Pediatr Gastroenterol Nutr | The rs72613567: TA Variant in the Hydroxysteroid 17-beta Dehydrogenase 13 Gene Reduces Liver Damage in Obese Children. | 2020 | Details |
A09341 | 31785086 | Obesity (Silver Spring) | Association of Hepatic Global DNA Methylation and Serum One-Carbon Metabolites with Histological Severity in Patients with NAFLD. | 2019 | Details |
A09342 | 31784293 | Arch Pediatr | Feeding problems and gastrointestinal diseases in Down syndrome. | 2019 | Details |
A09343 | 31783920 | Syst Rev | Diabetes drugs for nonalcoholic fatty liver disease: a systematic review. | 2019 | Details |
A09345 | 31783635 | Nutrients | Circulating miRNAs as Biomarkers of Obesity and Obesity-Associated Comorbidities in Children and Adolescents: A Systematic Review. | 2019 | Details |
A09349 | 31782258 | Physiol Rep | SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone prevents progression of nonalcoholic steatohepatitis in a type 2 diabetes rodent model. | 2019 | Details |
A09351 | 31782025 | Eur J Clin Microbiol Infect Dis | Nonalcoholic fatty liver disease as a risk factor for Clostridioides difficile infection. | 2019 | Details |
A09353 | 31781899 | Abdom Radiol (NY) | Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity. | 2020 | Details |
A09354 | 31781248 | Stem Cells Int | Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice. | 2019 | Details |
A09358 | 31779730 | Br J Nutr | Dietary protein insufficiency: an important consideration in fatty liver disease? | 2019 | Details |
A09360 | 31778277 | Pediatr Diabetes | Prevalence of responders for hepatic fat, adiposity and liver enzyme levels in response to a lifestyle intervention in children with overweight/obesity: EFIGRO randomized controlled trial. | 2019 | Details |
A09361 | 31777896 | Food Funct | Attenuation of metabolic syndrome in the ob/ob mouse model by resistant starch intervention is dose dependent. | 2019 | Details |
A09369 | 31775341 | Int J Mol Sci | Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction. | 2019 | Details |
A09371 | 31774328 | Expert Rev Gastroenterol Hepatol | The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer. | 2019 | Details |
A09377 | 31770380 | PLoS One | The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women. | 2019 | Details |
A09378 | 31770351 | Gastroenterol Nurs | Aminotransferase Ratio Is a Useful Index for Hepatosteatosis in Children and Adolescents: A Cross-Sectional Observational Study. | 2020 | Details |
A09380 | 31770104 | Eur J Endocrinol | Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study. | 2020 | Details |
A09381 | 31769484 | Clin Sci (Lond) | Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats. | 2019 | Details |
A09386 | 31766373 | J Clin Med | Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review. | 2019 | Details |
A09387 | 31765666 | Metabolism | Low levels of total and high-molecular-weight adiponectin may predict non-alcoholic fatty liver in Korean adults. | 2019 | Details |
A09392 | 31762620 | Saudi J Biol Sci | Lifestyle interventions for non-alcoholic fatty liver disease. | 2019 | Details |
A09393 | 31762148 | Liver Int | Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study. | 2019 | Details |
A09394 | 31761566 | Cell Metab | Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis. | 2019 | Details |
A09396 | 31760676 | Intern Med J | Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. | 2020 | Details |
A09397 | 31760464 | Cell Mol Life Sci | Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis. | 2020 | Details |
A09398 | 31760381 | J Basic Clin Physiol Pharmacol | Development of nonalcoholic fatty liver disease model by high-fat diet in rats. | 2019 | Details |
A09399 | 31760308 | J Nutr Biochem | Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice. | 2019 | Details |
A09401 | 31759197 | J Nutr Biochem | Mitigation of nonalcoholic fatty liver disease in high-fat-fed mice by the combination of decaffeinated green tea extract and voluntary exercise. | 2019 | Details |
A09402 | 31759125 | Peptides | The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
A09405 | 31758951 | Metabolism | Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity. | 2019 | Details |
A09410 | 31758299 | Rev Endocr Metab Disord | Ghrelin and liver disease. | 2020 | Details |
A09416 | 31757728 | Presse Med | [Epidemiology of non-alcoholic steatohepatitis. Extent/burden of the problem and its impact on public health]. | 2019 | Details |
A09417 | 31757727 | Presse Med | [Nutritional Management of Nonalcoholic fatty liver disease (NAFLD)]. | 2019 | Details |
A09418 | 31757631 | Nutr Res | Steatosis and gut microbiota dysbiosis induced by high-fat diet are reversed by 1-week chow diet administration. | 2019 | Details |
A09425 | 31754954 | Hormones (Athens) | Obese boys with low concentrations of high-density lipoprotein cholesterol are at greater risk of hepatosteatosis. | 2019 | Details |
A09428 | 31754142 | Sci Rep | New insight into the mechanisms of ectopic fat deposition improvement after bariatric surgery. | 2019 | Details |
A09429 | 31753536 | Mayo Clin Proc | Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation. | 2019 | Details |
A09432 | 31752378 | Nutrients | Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter? | 2019 | Details |
A09436 | 31750276 | Front Pediatr | Including Fibroblast Growth Factor-21 in Combined Biomarker Panels Improves Predictions of Liver Steatosis Severity in Children. | 2019 | Details |
A09437 | 31749914 | Gastroenterol Hepatol Bed Bench | The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider. | 2019 | Details |
A09442 | 31748681 | Lab Invest | Maternal diet intervention before pregnancy primes offspring lipid metabolism in liver. | 2019 | Details |
A09444 | 31746482 | Aliment Pharmacol Ther | Systematic review: chronic viral hepatitis and metabolic derangement. | 2019 | Details |
A09447 | 31745030 | Indian J Med Microbiol | Gut microbiota and its mysteries. | 2020 | Details |
A09453 | 31742325 | Clin Sci (Lond) | Processes exacerbating apoptosis in non-alcoholic steatohepatitis. | 2019 | Details |
A09472 | 31731192 | Biomed Pharmacother | Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease. | 2019 | Details |
A09474 | 31730978 | Int J Biol Macromol | Resistant starch from green banana (Musa sp.) attenuates non-alcoholic fat liver accumulation and increases short-chain fatty acids production in high-fat diet-induced obesity in mice. | 2019 | Details |
A09475 | 31730885 | Toxicol Lett | In vitro and in vivo approaches for identifying the role of aryl hydrocarbon receptor in the development of nonalcoholic fatty liver disease. | 2019 | Details |
A09478 | 31728429 | Transl Gastroenterol Hepatol | Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies? | 2019 | Details |
A09486 | 31726714 | Nutrients | Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity: Results from a Cross-Sectional Study. | 2019 | Details |
A09487 | 31726709 | Int J Mol Sci | A Newly Established Murine Cell Line as a Model for Hepatocellular Cancer in Non-Alcoholic Steatohepatitis. | 2019 | Details |
A09490 | 31725632 | Medicine (Baltimore) | Nonalcoholic fatty liver disease is associated with both subcutaneous and visceral adiposity: A cross-sectional study. | 2019 | Details |
A09492 | 31724099 | Dig Dis Sci | Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients. | 2019 | Details |
A09498 | 31718984 | J Pharm Biomed Anal | Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet. | 2019 | Details |
A09501 | 31717994 | Nutrients | Dysregulated Iron Metabolism-Associated Dietary Pattern Predicts an Altered Body Composition and Metabolic Syndrome. | 2019 | Details |
A09504 | 31717576 | Int J Mol Sci | The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives. | 2019 | Details |
A09505 | 31717414 | Int J Mol Sci | Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway. | 2019 | Details |
A09508 | 31717271 | J Clin Med | The Association between SOCS1-1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients. | 2019 | Details |
A09510 | 31715523 | J Nutr Biochem | Interactive effects of maternal and weaning high linoleic acid intake on hepatic lipid metabolism, oxylipins profile and hepatic steatosis in offspring. | 2019 | Details |
A09514 | 31714387 | Eur J Gastroenterol Hepatol | Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. | 2020 | Details |
A09519 | 31711944 | Surg Obes Relat Dis | Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria. | 2019 | Details |
A09523 | 31709830 | Am J Physiol Gastrointest Liver Physiol | CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. | 2019 | Details |
A09535 | 31705444 | Hepatol Int | Sarcopenia and fatty liver disease. | 2019 | Details |
A09536 | 31705397 | J Endocrinol Invest | L-Carnitine counteracts in vitro fructose-induced hepatic steatosis through targeting oxidative stress markers. | 2019 | Details |
A09541 | 31701393 | Hepatol Int | Hepatocellular carcinoma and non-alcoholic fatty liver disease. | 2019 | Details |
A09549 | 31697646 | Aging (Albany NY) | Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice. | 2019 | Details |
A09551 | 31696774 | Gut Microbes | Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. | 2019 | Details |
A09552 | 31696690 | Clin Mol Hepatol | Application of transient elastography in nonalcoholic fatty liver disease. | 2019 | Details |
A09553 | 31696128 | Hypoxia (Auckl) | Hypoxia Suppresses High Fat Diet-Induced Steatosis And Development Of Hepatic Adenomas. | 2019 | Details |
A09558 | 31695245 | J Clin Exp Hepatol | Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A09563 | 31693842 | Ultrasonography | Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis. | 2019 | Details |
A09566 | 31692556 | Diabetes Metab Syndr Obes | Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice. | 2019 | Details |
A09567 | 31692530 | Pediatric Health Med Ther | Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management. | 2019 | Details |
A09572 | 31691175 | Curr Obes Rep | Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives. | 2019 | Details |
A09574 | 31690932 | J Clin Endocrinol Metab | Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. | 2020 | Details |
A09575 | 31689910 | Nutrients | The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. | 2019 | Details |
A09585 | 31686320 | Sci China Life Sci | Regulation of glucose and lipid metabolism in health and disease. | 2019 | Details |
A09587 | 31685793 | Nutr Diabetes | Energy restriction in obese women suggest linear reduction of hepatic fat content and time-dependent metabolic improvements. | 2019 | Details |
A09589 | 31684925 | BMC Complement Altern Med | The potential of antioxidant-rich Maoberry (Antidesma bunius) extract on fat metabolism in liver tissues of rats fed a high-fat diet. | 2019 | Details |
A09593 | 31682638 | PLoS One | Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population. | 2019 | Details |
A09594 | 31682518 | Endocr Pract | CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY. | 2019 | Details |
A09597 | 31680967 | Front Pharmacol | Chinese Herbal Formula (CHF03) Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) Through Inhibiting Lipogenesis and Anti-Oxidation Mechanisms. | 2019 | Details |
A09600 | 31679693 | Biochem Biophys Res Commun | Identification of isotschimgine as a novel farnesoid X receptor agonist with potency for the treatment of obesity in mice. | 2019 | Details |
A09601 | 31679316 | Clin Mol Hepatol | Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017. | 2019 | Details |
A09604 | 31677889 | Nutr Metab Cardiovasc Dis | Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD. | 2019 | Details |
A09610 | 31676768 | Exp Mol Med | Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases. | 2019 | Details |
A09611 | 31675427 | Hepatology | Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A09614 | 31673703 | Endocrinology | Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression. | 2020 | Details |
A09619 | 31672578 | Life Sci | Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell. | 2019 | Details |
A09624 | 31671589 | Nutrients | Effects of Periodic Fasting on Fatty Liver Index-A Prospective Observational Study. | 2019 | Details |
A09630 | 31668939 | J Ren Nutr | The Separate Contributions of Visceral Fat and Liver Fat to Chronic Kidney Disease-Related Renal Outcomes. | 2019 | Details |
A09638 | 31665722 | Cardiology | Association between Nonalcoholic Fatty Liver and Gensini Score in Patients with Coronary Heart Disease: A Cross-Sectional Study. | 2019 | Details |
A09639 | 31665561 | Liver Transpl | Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. | 2020 | Details |
A09642 | 31661783 | Metabolites | A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Ldlr -/- Mice. | 2019 | Details |
A09644 | 31661720 | Hepatol Res | Changes of gut microbiota during silybin-mediated treatment of high-fat diet-induced non-alcoholic fatty liver disease in mice. | 2020 | Details |
A09649 | 31659105 | Cancer Genomics Proteomics | Synergism of Adipocytokine Profile and ADIPOQ/TNF-α Polymorphisms in NAFLD-associated MetS Predict Colorectal Liver Metastases Outgrowth. | 2020 | Details |
A09656 | 31657148 | Obesity (Silver Spring) | Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis. | 2019 | Details |
A09657 | 31657145 | Pediatr Obes | Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease. | 2019 | Details |
A09658 | 31656991 | Rev Endocr Metab Disord | Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease. | 2019 | Details |
A09659 | 31656291 | J Med Invest | The Effect of Laparoscopic Sleeve Gastrectomy on Obesity and Obesity-related Disease : the Results of 10 Initial Cases. | 2019 | Details |
A09661 | 31655133 | J Hepatol | β-Klotho gene variation is associated with liver damage in children with NAFLD. | 2019 | Details |